UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.682

Sortiert nach

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Bone marrow transplantation (Basingstoke), 2017-02, Vol.52 (2), p.173-182

2017

Volltextzugriff (PDF)

Secondary solid cancer screening following hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2015-08, Vol.50 (8), p.1013-1023

2015

Volltextzugriff (PDF)

Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis

Bone marrow transplantation (Basingstoke), 2016-12, Vol.51 (12), p.1599-1601

2016

Volltextzugriff (PDF)

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2009-01, Vol.43 (1), p.49-54

2009

Volltextzugriff (PDF)

Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant

Bone marrow transplantation (Basingstoke), 2017-04, Vol.52 (4), p.625-626

2017

Volltextzugriff (PDF)

Characteristics of chronic GVHD after cord blood transplantation

Bone marrow transplantation (Basingstoke), 2013-10, Vol.48 (10), p.1285-1290

2013

Volltextzugriff (PDF)

Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity

Bone marrow transplantation (Basingstoke), 2016-10, Vol.51 (10), p.1350-1353

2016

Volltextzugriff (PDF)

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

Bone marrow transplantation (Basingstoke), 2016-12, Vol.51 (12), p.1573-1578

2016

Volltextzugriff (PDF)

Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD

Bone marrow transplantation (Basingstoke), 2014-04, Vol.49 (4), p.532-538

2014

Volltextzugriff (PDF)

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD

Bone marrow transplantation (Basingstoke), 2009-12, Vol.44 (11), p.739-748

2009

Volltextzugriff (PDF)

Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.315-316

2014

Volltextzugriff (PDF)

Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2011-04, Vol.46 (4), p.539-544

2011

Volltextzugriff (PDF)

Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2003-09, Vol.32 (5), p.515-522

2003

Volltextzugriff (PDF)

Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2007-11, Vol.40 (10), p.965-971

2007

Volltextzugriff (PDF)

Implications of early airflow decline after myeloablative allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2004-04, Vol.33 (7), p.759-764

2004

Volltextzugriff (PDF)

Recurrence of β-thalassemia major more than 20 years after HLA-identical sibling BMT treated successfully with donor lymphocyte infusion

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.1037-1038

2011

Volltextzugriff (PDF)

Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens

Bone marrow transplantation (Basingstoke), 2008-05, Vol.41 (10), p.887-893

2008

Volltextzugriff (PDF)

Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2005-08, Vol.36 (4), p.337-341

2005

Volltextzugriff (PDF)

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

Haematologica (Roma), 2015-06, Vol.100 (6), p.842

2015

Volltextzugriff (PDF)

Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation

Bone marrow transplantation (Basingstoke), 2004-02, Vol.33 (3), p.337-346

2004

Volltextzugriff (PDF)

PCR-based prevalence of a fatal reovirus of the blue crab, Callinectes sapidus (Rathbun) along the northern Atlantic coast of the USA

Journal of fish diseases, 2016-06, Vol.39 (6), p.705-714

2016

Volltextzugriff (PDF)

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning

Bone marrow transplantation (Basingstoke), 2005-02, Vol.35 (3), p.277-282

2005

Volltextzugriff (PDF)

Low‐dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA‐matched related donors in patients with Fanconi anaemia

British journal of haematology, 2005-07, Vol.130 (1), p.99-106

2005

Volltextzugriff (PDF)

Cyclophosphamide-Based In Vivo T-Cell Depletion for HLA-Haploidentical Transplantation in Fanconi Anemia

Pediatric hematology and oncology, 2012-09, Vol.29 (6), p.568-578

2012

Volltextzugriff (PDF)

Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia

Bone marrow transplantation (Basingstoke), 2021-12, Vol.56 (12), p.3042-3048

2021

Volltextzugriff (PDF)

1 – 25 von 1.682

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.491)
Mit Volltextzugriff
(1.594)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(854)
Life Sciences & Biomedicine
(508)
Humans
(428)
Physics
(407)
Physics Of Elementary Particles And Fields
(325)
Hadron-Hadron Scattering
(320)
Female
(309)
Physical Sciences
(306)
Male
(275)
Elementary Particles
(266)
Quantum Field Theories
(261)
Quantum Field Theory
(261)
String Theory
(261)
Physics And Astronomy
(257)
Regular Article - Experimental Physics
(243)
Adult
(240)
Luminosity
(225)
Middle Aged
(222)
Hematology
(214)
Classical And Quantum Gravitation
(211)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Secondary solid cancer screening following hematopoietic cell transplantation

Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation

Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant

Characteristics of chronic GVHD after cord blood transplantation

Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD

Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions

Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation

Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation

Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation

Implications of early airflow decline after myeloablative allogeneic stem cell transplantation

Recurrence of β-thalassemia major more than 20 years after HLA-identical sibling BMT treated successfully with donor lymphocyte infusion

Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens

Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation

PCR-based prevalence of a fatal reovirus of the blue crab, Callinectes sapidus (Rathbun) along the northern Atlantic coast of the USA

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning

Low‐dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA‐matched related donors in patients with Fanconi anaemia

Cyclophosphamide-Based In Vivo T-Cell Depletion for HLA-Haploidentical Transplantation in Fanconi Anemia

Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia

Suchergebnisse filtern